4Toi M. The expression of vascular endothelial growth factor in tumor[J]. Jpn J Cancer Res,1994,85(10):1045-1049.
5Kitamura M, Toi M, Arai K, et al. Concentrations of vascular endothelial growth factor in sera of gastric cancer patents[J]. Oncol Reo,1998,5(6):1419-1424.
6Ikeda N, Adachi M, Taki T, et al. Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer, 1999, 79:1553-1563.
7Holmgren L. Antiangiogenesis restricted tumor dormancy. CancerMetastasis Rev, 1996,15: 241-245.
8Asahara T, Bauters C, Zheng L P, et al. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor onangiogenesis in vivo. Circulation, 1995,92(9 suppl):365 371.
9Fujimoto K, Hosotani R, Wada M, et al. Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, andits relationship to angiogenesis. Eur J Cancer, 1998, 34:14391447.
10Yoshiji H, Gomez DE, Shibuya M, et al. Expression of vascularendothelial growth factor, its receptor, and other angiogenic factorsin human breast cancer. Cancer Res, 1996,56:2013 2016.
